Şule Öztürk Sarı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Şule Öztürk Sarı has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Can Baykal
Department of Dermatology and Venereology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye
4 shared publications - Nesimi Büyükbabani
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
4 shared publications - Orhun Cig Taskin
Department of Pathology, Koc University School of Medicine, Istanbul, Turkey
4 shared publications - Yasemin Ozluk
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
4 shared publications Metin Keskin
Department of Surgery, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
2 shared publicationsMine Gulluoglu
Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7227
Cutaneous Metastases: An Update on Their Origins and Clinical Presentations
Introduction: Cutaneous metastases can originate from different organ systems and reach the skin through various pathways. Hence, they can present in a wide range of clinical patterns. Objectives: We aimed to evaluate the clinical features of cutaneous metastases in a large, well-documented series and compare them with the literature. Methods: Patients diagnosed with cutaneous metastasis in a 20-year period were evaluated in this retrospective single-center study. Metastases of hematologic malignancies, melanoma, and major epithelial malignancies of skin were excluded. Results: In all, 105 patients were included in the study. The most common primary origin was breast (n=42), followed by oral and nasal mucosal squamous cell carcinoma (SCC) (n=7), and gastric cancer (n=6). Chest was the most commonly involved site (n=51), followed by head (n=26). Breast cancer and mucosal SCC tended to metastasize locally, while colon, bladder, lung, and gastric cancers had higher rates of distant metastasis. Fourteen patients (13.3%) presented with multiple clinical patterns. Patients most commonly presented with nodules (n=81), although sclerodermoid (n=12), carcinoma erysipeloides (n=11), and erythema annulare centrifugum-like (EAC-like) (n=9) presentations were observed at a higher rate than the literature. Among various nodular patterns, multiple isolated nodules were the most common. Ulceration was observed at the highest rate in the literature (31.4%), and was mostly associated with nodular metastases. Conclusions: Cutaneous metastases can have a variety of presentations, sometimes with multiple patterns observed simultaneously. In the differential diagnosis of persistent EAC-like lesions, circumscribed sclerodermoid lesions, and ulcerated nodules not otherwise explained, cutaneous metastases should be considered.
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7227
Open AccessCutaneous Metastases: An Update on Their Origins and Clinical Presentations
Introduction: Cutaneous metastases can originate from different organ systems and reach the skin through various pathways. Hence, they can present in a wide range of clinical patterns. Objectives: We aimed to evaluate the clinical features of cutaneous metastases in a large, well-documented series and compare them with the literature. Methods: Patients diagnosed with cutaneous metastasis in a 20-year period were evaluated in this retrospective single-center study. Metastases of hematologic malignancies, melanoma, and major epithelial malignancies of skin were excluded. Results: In all, 105 patients were included in the study. The most common primary origin was breast (n=42), followed by oral and nasal mucosal squamous cell carcinoma (SCC) (n=7), and gastric cancer (n=6). Chest was the most commonly involved site (n=51), followed by head (n=26). Breast cancer and mucosal SCC tended to metastasize locally, while colon, bladder, lung, and gastric cancers had higher rates of distant metastasis. Fourteen patients (13.3%) presented with multiple clinical patterns. Patients most commonly presented with nodules (n=81), although sclerodermoid (n=12), carcinoma erysipeloides (n=11), and erythema annulare centrifugum-like (EAC-like) (n=9) presentations were observed at a higher rate than the literature. Among various nodular patterns, multiple isolated nodules were the most common. Ulceration was observed at the highest rate in the literature (31.4%), and was mostly associated with nodular metastases. Conclusions: Cutaneous metastases can have a variety of presentations, sometimes with multiple patterns observed simultaneously. In the differential diagnosis of persistent EAC-like lesions, circumscribed sclerodermoid lesions, and ulcerated nodules not otherwise explained, cutaneous metastases should be considered.
- 22 April 2026
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (8) , 749-755
Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi
Background: Malignant melanoma (MM) and proliferative nodules (PN) may arise in large/giant congenital melanocytic nevi (LCMN/GCMN), posing clinical and pathological challenges in differential diagnosis. We investigated immunohistochemical expression of PRAME and H3K27me3 in MMs and PNs in LCMN/GCMN, examining their potential utility. Methods: Three MMs and six PNs arising in LCMN/GCMN were subjected to immunohistochemical analyses. PRAME staining was scored as percentage of positive cells and H3K27me3 as follows: score0 = no staining; score1 = 1%–25%; score2 = 26%–50%; score3 = 51%–75%; score4 = 76%–100% staining in tumor cells. BRAF , NRAS , KIT , GNAQ, GNA11 , and TERT mutations were tested by polymerase chain reaction‐based direct Sanger sequencing for 3 MMs. Results: Mean age was 6.2 (0–24), 33.6% were male. All MM cases were metastatic and two died of disease. CMN components were negative for PRAME in all cases, whereas 3 MMs and 1 PN were positive (> 90%). MMs showed loss of H3K27me3 expression, whereas expression was retained in all PNs. Two cases showed NRAS mutations in both MM and nevus components. Conclusion: Combined use of PRAME and H3K27me3 can be utilized to discriminate MM from PN arising in LCMN/GCMN if validated on larger cohorts.
- 22 April 2026
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (8) , 749-755
Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi
Background: Malignant melanoma (MM) and proliferative nodules (PN) may arise in large/giant congenital melanocytic nevi (LCMN/GCMN), posing clinical and pathological challenges in differential diagnosis. We investigated immunohistochemical expression of PRAME and H3K27me3 in MMs and PNs in LCMN/GCMN, examining their potential utility. Methods: Three MMs and six PNs arising in LCMN/GCMN were subjected to immunohistochemical analyses. PRAME staining was scored as percentage of positive cells and H3K27me3 as follows: score0 = no staining; score1 = 1%–25%; score2 = 26%–50%; score3 = 51%–75%; score4 = 76%–100% staining in tumor cells. BRAF , NRAS , KIT , GNAQ, GNA11 , and TERT mutations were tested by polymerase chain reaction‐based direct Sanger sequencing for 3 MMs. Results: Mean age was 6.2 (0–24), 33.6% were male. All MM cases were metastatic and two died of disease. CMN components were negative for PRAME in all cases, whereas 3 MMs and 1 PN were positive (> 90%). MMs showed loss of H3K27me3 expression, whereas expression was retained in all PNs. Two cases showed NRAS mutations in both MM and nevus components. Conclusion: Combined use of PRAME and H3K27me3 can be utilized to discriminate MM from PN arising in LCMN/GCMN if validated on larger cohorts.
- 7 April 2026
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 48 (7) , 509-514
Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis
Background: Atypical fibroxanthoma (AFX) is an uncommon cutaneous neoplasm predominantly affecting elderly individuals in sun-exposed areas. Despite its alarming histopathological features, AFX typically exhibits an indolent clinical course. Diagnosis remains challenging due to overlapping features with other aggressive cutaneous malignancies, especially malignant melanoma. Methods: We retrospectively analyzed 15 cases of AFX diagnosed between 2009 and 2024. Comprehensive immunohistochemical profiling was performed, including CD10, CD68, S100, Melan-A, HMB45, CD31, CD34, ERG, cytokeratins, P40, P63, SMA, Desmin, and newly, PRAME (clone EPR20330). Clinical and follow-up data were collected from medical records. Results: The cohort had a mean age of 72.9 years, with a male predominance (66.7%). The scalp was the most frequent tumor site (40.0%). All cases demonstrated diffuse block-type CD10 positivity and were uniformly negative for PRAME. Occasional weak staining for melanocytic markers was observed in a minority of cases. After a mean follow-up of 84.0 months, all patients were alive. Conclusion: A comprehensive immunohistochemical panel is essential for the accurate diagnosis of AFX. The absence of PRAME expression, together with block-type CD10 positivity, supports the distinction of AFX from malignant melanoma and other histological mimics, facilitating appropriate clinical management.
- 7 April 2026
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 48 (7) , 509-514
Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis
Background: Atypical fibroxanthoma (AFX) is an uncommon cutaneous neoplasm predominantly affecting elderly individuals in sun-exposed areas. Despite its alarming histopathological features, AFX typically exhibits an indolent clinical course. Diagnosis remains challenging due to overlapping features with other aggressive cutaneous malignancies, especially malignant melanoma. Methods: We retrospectively analyzed 15 cases of AFX diagnosed between 2009 and 2024. Comprehensive immunohistochemical profiling was performed, including CD10, CD68, S100, Melan-A, HMB45, CD31, CD34, ERG, cytokeratins, P40, P63, SMA, Desmin, and newly, PRAME (clone EPR20330). Clinical and follow-up data were collected from medical records. Results: The cohort had a mean age of 72.9 years, with a male predominance (66.7%). The scalp was the most frequent tumor site (40.0%). All cases demonstrated diffuse block-type CD10 positivity and were uniformly negative for PRAME. Occasional weak staining for melanocytic markers was observed in a minority of cases. After a mean follow-up of 84.0 months, all patients were alive. Conclusion: A comprehensive immunohistochemical panel is essential for the accurate diagnosis of AFX. The absence of PRAME expression, together with block-type CD10 positivity, supports the distinction of AFX from malignant melanoma and other histological mimics, facilitating appropriate clinical management.
- Open Access
Effect of Vinblastine Timing on Skin Graft Healing in a Rat Model
Background and Objectives: Chemotherapeutic agents are known to disrupt wound healing; however, the influence of administration timing on skin graft repair remains insufficiently characterized. This study aimed to investigate the time-dependent effects of vinblastine exposure on full-thickness skin graft healing in a rat model. Materials and Methods: Twenty-four female Wistar albino rats were allocated into four groups (n = 6). The control group underwent grafting without pharmacologic intervention, whereas the experimental groups received a single intraperitoneal dose of vinblastine (2 mg/kg), followed by grafting in the first week, second week and third week after administration. Graft specimens were harvested on postoperative day 7 for histopathological evaluation performed by a blinded pathologist. Hematoxylin-eosin-stained sections were scored for inflammation, granulation tissue formation, fibroblast maturation, collagen deposition, re-epithelialization, and neovascularization. Intergroup comparisons were conducted using the Kruskal–Wallis test with Dunn–Bonferroni post hoc analysis. Results: Vinblastine exposure produced significant time-dependent differences in several healing parameters. Fibroblast maturation was markedly reduced in the second-week graft group compared with controls (p < 0.001). Re-epithelialization was significantly delayed in the second- and third-week groups (p = 0.033). Granulation tissue formation differed between groups (p = 0.014), with higher early scores observed in the first-week group. Notably, neovascularization was significantly greater in the third-week group than in the control and second-week groups (p = 0.010), suggesting partial recovery of angiogenic activity over time. No significant differences were detected in inflammation or collagen deposition. Conclusions: Vinblastine exposure appears to exert time-dependent effects on skin graft healing, with the second week representing a period of less favorable histopathological repair. Partial recovery observed with later grafting suggests that the interval between chemotherapeutic exposure and reconstructive procedures may influence graft outcomes and support improved surgical planning.
Open AccessEffect of Vinblastine Timing on Skin Graft Healing in a Rat Model
Background and Objectives: Chemotherapeutic agents are known to disrupt wound healing; however, the influence of administration timing on skin graft repair remains insufficiently characterized. This study aimed to investigate the time-dependent effects of vinblastine exposure on full-thickness skin graft healing in a rat model. Materials and Methods: Twenty-four female Wistar albino rats were allocated into four groups (n = 6). The control group underwent grafting without pharmacologic intervention, whereas the experimental groups received a single intraperitoneal dose of vinblastine (2 mg/kg), followed by grafting in the first week, second week and third week after administration. Graft specimens were harvested on postoperative day 7 for histopathological evaluation performed by a blinded pathologist. Hematoxylin-eosin-stained sections were scored for inflammation, granulation tissue formation, fibroblast maturation, collagen deposition, re-epithelialization, and neovascularization. Intergroup comparisons were conducted using the Kruskal–Wallis test with Dunn–Bonferroni post hoc analysis. Results: Vinblastine exposure produced significant time-dependent differences in several healing parameters. Fibroblast maturation was markedly reduced in the second-week graft group compared with controls (p < 0.001). Re-epithelialization was significantly delayed in the second- and third-week groups (p = 0.033). Granulation tissue formation differed between groups (p = 0.014), with higher early scores observed in the first-week group. Notably, neovascularization was significantly greater in the third-week group than in the control and second-week groups (p = 0.010), suggesting partial recovery of angiogenic activity over time. No significant differences were detected in inflammation or collagen deposition. Conclusions: Vinblastine exposure appears to exert time-dependent effects on skin graft healing, with the second week representing a period of less favorable histopathological repair. Partial recovery observed with later grafting suggests that the interval between chemotherapeutic exposure and reconstructive procedures may influence graft outcomes and support improved surgical planning.
- Open Access
- 3 March 2025
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (2) , 157-163
Clinical Characteristics of Nail Unit Melanoma in Türkiye: The Experience of Two Tertiary Dermatology Centers
The literature on the clinical presentations of nail unit melanoma (NUM) in different countries is limited. To assess the specific clinical characteristics of NUM in Türkiye. A retrospective cross sectional study. Patients with NUM in two centers were retrospectively evaluated for their clinicopathological features, including the location, laterality, destruction of the nail plate, erosion or ulceration, presence of longitudinal melanonychia (LM), Hutchinson's sign (HS), and the absence of pigmentation and Breslow thickness. These variables were compared in terms of the main location of the NUMs (fingernail versus toenail). A total of 37 patients (54.1% female) of mean age 61.9 ± 14.8 years were enrolled. In most cases, NUMs were located in the fingernails (62.2%), with the most common location being the thumbnails (45.9%), followed by the big toenails (32.4%). Five cases had in situ melanoma presenting with LM. The mean Breslow thickness of invasive NUM lesions (n = 26) was 4.7 ± 4.1 mm (median: 3). Although all in situ NUMs were located on the hands, no statistically significant difference was noted in the Breslow thickness of invasive NUMs on the toenails and fingernails. NUMs were hypomelanotic/amelanotic in 10 (27%) patients. LM was clinically evident in 40.5% of the patients and was significantly more frequently observed on fingernails. The HS of the nail folds was noted in 40.5% of the patients, with the proximal (73.3%) and distal (73.3%) nail folds being most commonly involved. Total or partial destruction of the nail plate was recorded in 24.3% and 51.4% of the patients, respectively. Erosion and/or ulceration on the surface of the NUM was clinically present in most (75.7%) cases. Invasive NUMs associated with LM (n = 10) displayed partial destruction of the nail plate (n = 9), erosion and/or ulceration on the tumor surface (n = 7), and HS (n = 6). The clinical characteristics of patients with NUM, such as more common localization on the hands, a high rate of preference for thumbnail and big toe, and the ratio of HS, were similar to the studies reported from diverse countries. Partial destruction of the nail plate is an important clinical feature of NUM. Furthermore, LM is more frequently observed in NUMs on the fingernails.
- 3 March 2025
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (2) , 157-163
Open AccessClinical Characteristics of Nail Unit Melanoma in Türkiye: The Experience of Two Tertiary Dermatology Centers
The literature on the clinical presentations of nail unit melanoma (NUM) in different countries is limited. To assess the specific clinical characteristics of NUM in Türkiye. A retrospective cross sectional study. Patients with NUM in two centers were retrospectively evaluated for their clinicopathological features, including the location, laterality, destruction of the nail plate, erosion or ulceration, presence of longitudinal melanonychia (LM), Hutchinson's sign (HS), and the absence of pigmentation and Breslow thickness. These variables were compared in terms of the main location of the NUMs (fingernail versus toenail). A total of 37 patients (54.1% female) of mean age 61.9 ± 14.8 years were enrolled. In most cases, NUMs were located in the fingernails (62.2%), with the most common location being the thumbnails (45.9%), followed by the big toenails (32.4%). Five cases had in situ melanoma presenting with LM. The mean Breslow thickness of invasive NUM lesions (n = 26) was 4.7 ± 4.1 mm (median: 3). Although all in situ NUMs were located on the hands, no statistically significant difference was noted in the Breslow thickness of invasive NUMs on the toenails and fingernails. NUMs were hypomelanotic/amelanotic in 10 (27%) patients. LM was clinically evident in 40.5% of the patients and was significantly more frequently observed on fingernails. The HS of the nail folds was noted in 40.5% of the patients, with the proximal (73.3%) and distal (73.3%) nail folds being most commonly involved. Total or partial destruction of the nail plate was recorded in 24.3% and 51.4% of the patients, respectively. Erosion and/or ulceration on the surface of the NUM was clinically present in most (75.7%) cases. Invasive NUMs associated with LM (n = 10) displayed partial destruction of the nail plate (n = 9), erosion and/or ulceration on the tumor surface (n = 7), and HS (n = 6). The clinical characteristics of patients with NUM, such as more common localization on the hands, a high rate of preference for thumbnail and big toe, and the ratio of HS, were similar to the studies reported from diverse countries. Partial destruction of the nail plate is an important clinical feature of NUM. Furthermore, LM is more frequently observed in NUMs on the fingernails.
- 10 December 2024
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 47 (4) , 334-335
PRAME as a Diagnostic Marker in Desmoplastic Melanocytic Lesions: Insights and Challenges
- 10 December 2024
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 47 (4) , 334-335
PRAME as a Diagnostic Marker in Desmoplastic Melanocytic Lesions: Insights and Challenges
- Open Access
- 23 September 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (Suppl 1) , 25-29
A Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report
Journal of Clinical Research in Pediatric Endocrinology
- 23 September 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (Suppl 1) , 25-29
Open AccessA Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report
Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 11 July 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (5) , 407-410
Diffuse Normolipemic Plane Xanthoma: Remarkable Dermatological Findings Observed in a Series of Patients
- 11 July 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (5) , 407-410
Open AccessDiffuse Normolipemic Plane Xanthoma: Remarkable Dermatological Findings Observed in a Series of Patients
- Open Access
- 1 January 2022
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 39 (1) , 23-30
Braf, nras, kit, tert, gnaq/gna11 mutation profile and histomorphological analysis of anorectal melanomas: a clinicopathologic study
Primary anorectal melanomas (AMs) are uncommon neoplasms with aggressive behavior. Molecular profile and clinicopathologic features of AMs are still not well established. In this study, we aimed to investigate BRAF, NRAS, KIT, TERT, and GNAQ/GNA11 mutation status and clinicopathologic features of AMs. All diagnostic slides of 15 AMs were reviewed. Histopathological and follow-up information were documented. Mutations in exon 15 of the BRAF gene; exons 2 and 3 of the NRAS gene; exons 9, 11, 13, 17, and 18 of the KIT gene; and exons 4 and 5 of the GNAQ/GNA11 genes and mutations in the promoter region of the TERT gene (chr.5, 1,295,228C > T and 1,295,250C > T) were analyzed. BRAF(V600E) and KIT(V555I and K642E) mutations were observed in one (7%) and two cases (14%), respectively. NRAS, TERT and GNAQ/GNA11 mutations were not detected. The mean age was 65. Patients presented with rectal mass, rectal bleeding, pain, and weight loss. 73% of the lesions were macroscopically polypoid. The most common tumor cell type was epithelioid. Mean tumor thickness was 10.4 mm. One third of the cases lacked pigmentation. In situ melanoma was present in one third of the cases. Among 14 patients with follow-up data, 12 succumbed to disease. The mean overall survival was 36 months. AMs are uncommon tumors with dismal survival, usually occurring in the elderly in various gross and microscopic appearances. In terms of molecular profile, BRAF and KIT mutations are rarely detected. Profiling of larger cohorts is required to elucidate the pathogenesis and to identify potential molecular indicators that may contribute to the development of individualized targeted therapies.
- 1 January 2022
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 39 (1) , 23-30
Open AccessBraf, nras, kit, tert, gnaq/gna11 mutation profile and histomorphological analysis of anorectal melanomas: a clinicopathologic study
Primary anorectal melanomas (AMs) are uncommon neoplasms with aggressive behavior. Molecular profile and clinicopathologic features of AMs are still not well established. In this study, we aimed to investigate BRAF, NRAS, KIT, TERT, and GNAQ/GNA11 mutation status and clinicopathologic features of AMs. All diagnostic slides of 15 AMs were reviewed. Histopathological and follow-up information were documented. Mutations in exon 15 of the BRAF gene; exons 2 and 3 of the NRAS gene; exons 9, 11, 13, 17, and 18 of the KIT gene; and exons 4 and 5 of the GNAQ/GNA11 genes and mutations in the promoter region of the TERT gene (chr.5, 1,295,228C > T and 1,295,250C > T) were analyzed. BRAF(V600E) and KIT(V555I and K642E) mutations were observed in one (7%) and two cases (14%), respectively. NRAS, TERT and GNAQ/GNA11 mutations were not detected. The mean age was 65. Patients presented with rectal mass, rectal bleeding, pain, and weight loss. 73% of the lesions were macroscopically polypoid. The most common tumor cell type was epithelioid. Mean tumor thickness was 10.4 mm. One third of the cases lacked pigmentation. In situ melanoma was present in one third of the cases. Among 14 patients with follow-up data, 12 succumbed to disease. The mean overall survival was 36 months. AMs are uncommon tumors with dismal survival, usually occurring in the elderly in various gross and microscopic appearances. In terms of molecular profile, BRAF and KIT mutations are rarely detected. Profiling of larger cohorts is required to elucidate the pathogenesis and to identify potential molecular indicators that may contribute to the development of individualized targeted therapies.
- Open Access
- 10 November 2021
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 39 (1) , 68-69
Pediatric Case of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity
- 10 November 2021
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 39 (1) , 68-69
Open AccessPediatric Case of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity